Congressional trading
Who in Congress traded ABT?
Abbott Laboratories Common Stock · classified as Health care. 45 disclosed transactions across 17 members.
45
Transactions
17
Members
21 / 23
Buys / sells
3
Filed late
Committee overlap
4 of 17 members who traded ABT sit on a committee with jurisdiction over Health care. This is a disclosed structural overlap, not evidence of wrongdoing. Nothing here asserts that any member acted on non-public information. Jurisdiction is mapped from published House and Senate committee rules — see the methodology.
Members
8 transactions- Partial sell2026-05-27$1,001 - $15,000(Joint)disclosed after 6dfiling
- Partial sell2025-07-18$1,001 - $15,000(Joint)disclosed after 20dfiling
- Partial sell2025-03-06$1,001 - $15,000(Joint)disclosed after 29dfiling
- Buy2025-02-13$1,001 - $15,000(Joint)disclosed after 20dfiling
- Buy2025-01-29$1,001 - $15,000(Joint)disclosed after 8dfiling
- Buy2025-01-28$1,001 - $15,000(Joint)disclosed after 9dfiling
5 transactions
5 transactions
4 transactions
4 transactionsCommittee overlap
2 transactionsCommittee overlap
2 transactions
2 transactions
2 transactions1 filed past the 45-day deadline
2 transactions
2 transactions
2 transactionsCommittee overlap1 filed past the 45-day deadline
1 transaction- Sell2026-07-17$1,001 - $15,000(Spouse)disclosed after 26dfiling
1 transactionCommittee overlap1 filed past the 45-day deadline- Sell2026-03-27$15,001 - $50,000disclosed after 116dfiling
1 transaction- Exchange2026-03-24$1,001 - $15,000disclosed after 10dfiling
1 transaction- Partial sell2025-02-24$1,001 - $15,000(Spouse)disclosed after 10dfiling
1 transaction- Sell2025-01-06$1,001 - $15,000(Spouse)disclosed after 35dfiling
Where this comes from
43 transactions from House Clerk Periodic Transaction Reports and 2 from Senate eFD filings. Amounts are the statutory brackets filers report — Congress does not disclose exact values. Senate filings carry one filing date per report rather than per transaction, so “disclosed after” for a Senate row is measured to the date the whole report was filed. This page is a conflict-of-interest disclosure, not investment advice or a trading signal.